Medline ® Abstract for Reference 226
of 'Infusion reactions to systemic chemotherapy'
Delayed life-threatening pneumonitis secondary to procarbazine.
Brooks BJ Jr, Hendler NB, Alvarez S, Ancalmo N, Grinton SF
Am J Clin Oncol. 1990;13(3):244.
A patient with advanced Hodgkin's disease being treated with MOPP chemotherapy presented with delayed life-threatening pulmonary toxicity secondary to procarbazine. The pulmonary toxicity began 1 week after procarbazine had been discontinued and once recognized was successfully treated with intravenous steroids.
Ochsner Clinic of Baton Rouge, Louisiana 70816.